DICE Therapeutics Inc. (DICE)
47.55
0.03 (0.06%)
At close: Aug 08, 2023, 8:00 PM
0.06% (1D)
| Bid | n/a |
| Market Cap | 2.27B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -97.08M |
| EPS (ttm) | -2.17 |
| PE Ratio (ttm) | -21.912442396313363 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 4,332,848 |
| Avg. Volume (20D) | 1,753,229 |
| Open | 47.59 |
| Previous Close | 47.52 |
| Day's Range | 47.46 - 47.83 |
| 52-Week Range | 15.08 - 47.90 |
| Beta | 0.00 |
About DICE
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is DC-806, an oral antagonist of the pro-inflammatory signaling molecule, inter...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 15, 2021
Employees 71
Stock Exchange NASDAQ
Ticker Symbol DICE
Website https://www.dicemolecules.com